SCHEDULE 13D/A: Reed's Inc. Reports Major Shareholder Restructuring and Governance Updates

Reed's Inc. has announced significant changes in its major shareholder structure, with D&D Source of Life Holding Ltd. maintaining a controlling stake under new ownership and updated governance agreements.

Summary

• D&D Source of Life Holding Ltd. (D&D) continues to hold a controlling interest of 27,139,519 shares, representing 59.5% of Reed's, Inc.'s outstanding common stock.
• Shufen Deng has resigned as a director of D&D and transferred all her shares in D&D to Era Regenerative Medicine Limited, an unaffiliated third party, effective December 31, 2024.
• As a result of the transfer, Shufen Deng is no longer deemed a beneficial owner of Reed's, Inc. shares.
• The calculation of D&D's ownership percentage is based on a denominator of 45,603,355 shares, which includes 30,665,365 shares outstanding as of November 21, 2024, 232,108 shares from exercisable warrants, and 14,705,882 shares issued in a private placement on December 30, 2024.
• An Amendment to the Shareholders Agreement, dated January 24, 2025, updates D&D's rights: as long as D&D owns 25% or more of Reed's common stock, it can designate three individuals to the board (two of whom must be independent) and one board observer.
• The Amendment also stipulates that the board size will not exceed nine members without the consent of D&D's independent designated directors.
• A Board Observer Agreement was entered into on January 24, 2025, formalizing D&D's right to designate a board observer, Mr. Yumin Dai, who can attend and participate in board discussions, subject to confidentiality.
• The Joint Filing Agreement between D&D and Shufen Deng, originally dated June 5, 2023, was terminated effective December 31, 2024, and formally executed on January 24, 2025.

Sentiment

Score: 6

Explanation: The document is largely factual, detailing a change in beneficial ownership and related governance agreements. While the change in ultimate control of the major shareholder could introduce new dynamics, the continued significant stake and formalized governance rights for D&D suggest a structured transition rather than immediate negative implications. The sentiment is neutral to slightly positive due to the clarity of the new governance framework.

Positives

• The Amendment to Shareholders Agreement solidifies D&D's significant influence over Reed's, Inc.'s corporate governance, ensuring stability in strategic direction.
• The right to designate three board members, including two independent directors, and a board observer provides D&D with substantial oversight and input into company operations and strategy.
• The formalization of the board observer role with indemnification and expense reimbursement ensures D&D's representative can effectively monitor the company's activities.

Negatives

• Shufen Deng, a previous beneficial owner and director of D&D, has completely divested her beneficial ownership in Reed's, Inc. shares, which could signal a shift in long-term investor commitment from that individual.

Risks

• The change in ownership of D&D to Era Regenerative Medicine Limited, an unaffiliated third party, introduces a new controlling entity whose long-term strategic objectives for Reed's, Inc. may differ from previous management or shareholders.
• While the Shareholders Agreement outlines governance rights, potential disagreements could arise between the controlling shareholder (D&D/Era Regenerative Medicine Limited) and other shareholders or management regarding strategic decisions or board composition.

Future Outlook

The document primarily details past and current changes in ownership and governance structure. It indicates that D&D Source of Life Holding Ltd., under its new ownership by Era Regenerative Medicine Limited, will continue to exert significant influence over Reed's, Inc. through its board designation rights and board observer role, as long as its ownership stake remains above 25%.

Industry Context

This filing reflects a significant change in the controlling shareholder's ultimate beneficial ownership for Reed's, Inc., a company in the beverage industry. Such changes can impact a company's strategic direction, capital allocation, and operational focus, depending on the new controlling entity's objectives. While specific to Reed's, Inc., it highlights the dynamic nature of corporate control and governance in publicly traded companies.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The change in the ultimate beneficial owner of the controlling stake (D&D) to Era Regenerative Medicine Limited could lead to new strategic priorities or operational changes. The formalized governance rights for D&D ensure continued strong influence over the company's direction.
• Board of Directors: The board composition will be significantly influenced by D&D's right to designate three members, including two independent directors, and the presence of a board observer, potentially shifting internal dynamics and decision-making processes.

Next Steps

• D&D Source of Life Holding Ltd. will continue to exercise its right to designate three individuals to the board of Reed's, Inc., two of whom must be independent, as long as it owns 25% or more of the common stock.
• D&D Source of Life Holding Ltd. will continue to exercise its right to designate a board observer, Mr. Yumin Dai, to attend and participate in board meetings.
• The board size of Reed's, Inc. will not exceed nine members without the consent of D&D's independent designated directors.

Key Dates

Keywords

Reed's Inc, SEC filing, Schedule 13D, beneficial ownership, corporate governance, shareholder agreement, board observer, private placement, ownership change, Era Regenerative Medicine Limited, D&D Source of Life Holding Ltd